920 results on '"Van Vlierberghe, Hans"'
Search Results
2. Contributors
3. Outcome after liver transplantation
4. External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort
5. Adipose Tissue Insulin Resistance Correlates with Disease Severity in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Cohort Study
6. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
7. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
8. Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis
9. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
10. Illness cognitions and health-related quality of life in liver transplant patients related to length of stay, comorbidities and complications
11. THU-102-YI Specific glycomic profiles can identify patients at risk of poor transplant-free survival in primary biliary cholangitis
12. FRI-475-YI NADPH oxidase 1 inhibition as therapeutic strategy in hepatocellular carcinoma: insights from human-relevant models
13. OS-089-YI Transgenerational maternal obesity induces mitochondrial dysfunction and aggravates MASLD, which can be reversed by metabolic drug candidates
14. THU-123-YI External validation of the international autoimmune hepatitis group response criteria in a multicentric real-world cohort
15. SAT-268 Bariatric surgery is a major independent factor of disease progression in cirrhotic patients with alcohol-related liver disease
16. THU-020-YI Evolution of health-related quality of life in liver transplantation patients in relation to acceptance and metabolic liver disease
17. WED-531 The double-edged sword of bariatric surgery: extending the excluded limb can trigger bacterial translocation, liver inflammation and death
18. Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease
19. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis
20. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
21. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
22. Maternal and Perinatal Risk Factors for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review
23. A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation
24. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
25. Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy
26. Validation of a glycomics-based test associated with risk of HCC development in cirrhosis
27. The neurogliovascular unit in hepatic encephalopathy
28. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
29. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial
30. Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium
31. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model
32. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
33. Bariatric Surgery Patients Are at Risk for Alcoholic Liver Disease with Need for Liver Transplantation
34. NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
35. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons
36. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
37. Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease
38. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.
39. Patients hospitalized with alcohol‐related liver disease and prior bariatric surgery are more prone to develop acute‐on‐chronic liver failure
40. Osteopontin characterizes bile duct–associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis
41. Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody
42. Serum Glycomics on Postoperative Day 7 Are Associated With Graft loss Within 3 Months After Liver Transplantation Regardless of Early Allograft Dysfunction
43. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
44. Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium
45. Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction
46. Benign anastomotic biliary strictures untreatable by ERCP: a novel percutaneous balloon dilatation technique avoiding indwelling catheters
47. Chapter 3 - Outcome after liver transplantation
48. The pan-PPAR agonist lanifibranor decreases portal pressure in models of both hepatic and prehepatic portal hypertension
49. Application of updated diagnostic criteria for cirrhotic cardiomyopathy: evaluation of its clinical impact in liver transplantation candidates
50. The prognosis of hepatitis delta infections in Belgium is poor and determined by the hepatitis delta viremia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.